Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: A final report

Cancer

Volumn 79, Issue 9, 1997, Pages 1767-1775

  Crookes, Peter ^a   Leichman, Cynthia Gail ^a   Leichman, Lawrence ^a   Tan, Matthew ^a   Laine, Loren ^a   Stain, Steven ^a   Baranda, Joaquina ^a   Casagrande, Yolee ^a   Groshen, Susan ^a   Silberman, Howard ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

adjuvant chemotherapy; gastric carcinoma; intraperitoneal chemotherapy; preoperative chemotherapy

Indexed keywords

CISPLATIN; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; ONDANSETRON;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; DIARRHEA; FEMALE; GRANULOCYTOPENIA; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; JEJUNOSTOMY; KIDNEY FAILURE; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RASH; STOMACH ADENOCARCINOMA; STOMATITIS; SURVIVAL TIME; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLOXURIDINE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; INFUSIONS, PARENTERAL; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030911981     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970501)79:9<1767::AID-CNCR19>3.0.CO;2-W     Document Type: Article

References (23)

1. Leichman L. 1987 Cancer Program Report: gastric cancer, a survey of two years for the Los Angeles County + University of Southern California Medical Center. Annual Report 1988;11-2.
2. Diehl JT, Hermann RE, Cooperman AM, Hoerr SO. Gastric carcinoma: a ten year review. Ann Surg 1983;198:9-12.
3. Coombes RC, Schein PS, Chilvers CED, Wil J, Beretta G, Bliss JM, et al. A randomized trial comparing adjuvant fluorouracil, doxorubicin and mitomycin-c with no treatment in operable gastric cancer. J Clin Oncol 1990;8:1362-9.
4. Macdonald JS, Fleming TR, Peterson RF, Berenberg JL, McClure S, Chapman RA, et al. Adjuvant chemotherapy with 5FU, Adriamycin and Mitomycin-c (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: a Southwest Oncology Group Study. Ann Surg Oncol 1995;2:488-94.
5. Wilke H, Preusser P, Fink U, Gunzer U, Meyer J, Meyer JR, et al. Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin and cisplatin. J Clin Oncol 1989;7:1318-26.
6. Leichman L, Herskovic A, Leichman CG, Lattin PB, Steiger Z, Tapazaglou E, et al. Nonoperative therapy for squamous cell cancer of the esophagus. J Clin Oncol 1987;5:365-70.
7. Wisbeck WM, Becher EM, Russell AH. Adenocarcinoma of the stomach: autopsy observations with therapeutic implications for the radiation oncologist. Radiother Oncol 1986;7:13-8.
8. Gunderson LL, Sosin H. Adenocarcinoma of the stomach: areas of failure in a reoperation series (second or symptomatic look): clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1982;8:1-11.
9. Leichman CG, Leichman L, Spears CP, Rosen PJ, Muggia F, Jeffers S, et al. Biological modification of protracted infusion of 5-fluorouracil with weekly leucovorin. A dose seeking clinical trial for patients with disseminated gastrointestinal cancers. Cancer Chemother Pharmacol 1990;26:57-61.
10. Leichman L, Steiger Z, Seydel HG, Dindogru A, Kinzie J, Toben S, et al. Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approach. J Clin Oncol 1984;2:75-9.
11. Leichman L, Berry B. Cisplatin therapy for adenocarcinoma of the stomach. Semin Oncol 1991;18(Suppl 3):25-33.
12. Muggia FM, Chan KK, Russell C, Colombo N, Speyer JL, Sehgal K, et al. Phase I and pharmacologie evaluation of intraperitoneal 5-fluoro-2′-deoxyuridine. Cancer Chemother Pharmacol 1991;28:241-50.
13. Atiq OT, Kelsen DP, Shiu MH, Saltz L, Tong W, Niedzwiecki D, et al. Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer. J Clin Oncol 1993;11:425-33.
14. Howell SB, Pfeifle CE, Wung WE, Olshen RA, Lucas WE, Yon JL, et al. Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med 1982;97:845-91.
15. Markman M, Reichman B, Hakes T, Jones W, Lewis JL, Rubin S, et al. Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin. J Clin Oncol 1991;9:1801-5.
16. Leichman L, Silberman H, Leichman CG, Spears M, Ray M, Muggia FM, et al. Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California Pilot Program. J Clin Oncol 1992;10:1933-42.
17. Hagen JA, Peters JH, DeMeester TR. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg 1993; 106:850-9.
18. Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study in surgery and pathology. Jpn J Surg 1981;11:127-37.
19. Smith JW, Shiu MH, Kelsey L, Brennan MF. Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch Surg 1991;126:1469-73.
20. Leichman CG, Leichman L, Spears CP, Rosen PJ, Jeffers S, Groshen S, et al. Prolonged continuous infusion of fluorouracil with weekly bolus leucovorin: a phase II study in patients with colorectal cancer. J Natl Cancer Inst 1993;85:41-4.
21. Ajani JA, Ota DM, Jessup M, Ames FC, McBride C, Boddie A, et al. Resectable gastric carcinoma: an evaluation of preoperative and postoperative chemotherapy. Cancer 1991; 68:1501-6.
22. Lightdale CJ, Botet JF, Brennan MF, Shiu MH, Coit DG. Endoscopic ultrasonography (EUS) compared to computerized tomography (CT) for pre-operative staging of gastric cancer [abstract]. Gastrointest Endosc 1989;35:154-5.
23. Tio TL, Den Hartog Jager FC, Tytgat GNJ. The role of endoscopic ultrasonography in assessing local resectability of oesophagogastric malignancies. Accuracy, pitfalls, and predictability. Scand J Gastrenterol 1986;123(Suppl):78-86.